Vaxcyte, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 5 →InsidersNo open-market buys. 5 insiders sold $4.1M, 16 of 19 sales on a 10b5-1 plan.→HoldersFMR 14.4%Jupiter Topco 12.4%BlackRock 8.3%→PeersClosest companies: NVAX, IBRX, IVVD→
From the filings
Figures
- Net income
- −$298.4Mlast 12 months
- Operating cash flow
- −$769.9Mlast 12 months
- Cash and equivalents
- $183.2Mat the last balance sheet
- Shares outstanding
- 144.8M shareson issue